|
|
|
|
|
by usrusr
1780 days ago
|
|
Sure, and they can be proud of it and make all that money, but if you are in the market to ramp up a vaccination programme, you talk to Pfizer and not to Biontech. Almost like you'd go to Apple and not to FHG IIS for buying an iPod. (I'm pretty sure that this comparison is a wild exaggeration of what actually happened and that Biontech representatives were very much involved in all the talks, but I assume more in an expert advisor role than as someone with actual influence on the outcome) |
|